Atricure Stock Forecast

Buy or Hold candidate since Jul 02, 2026 Gain 30.98%

The AtriCure stock price gained 0.604% on the last trading day (Monday, 10th Aug 2026), rising from $41.39 to $41.64. It has now gained 6 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 1.86% from a day low at $41.45 to a day high of $42.22. The price has risen in 8 of the last 10 days and is up by 11.43% over the past 2 weeks. Volume fell on the last day by -5 thousand shares and in total, 511 thousand shares were bought and sold for approximately $21.27 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the upper part of a wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $42.72 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 49.63% during the next 3 months and, with a 90% probability hold a price between $54.77 and $63.92 at the end of this 3-month period.

ATRC Signals & Forecast

Mostly positive signals in the chart today. The AtriCure stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $39.62 and $34.57. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, July 31, 2026, and so far it has risen 10.28%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for AtriCure stock

AtriCure finds support from accumulated volume at $40.89 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.770 between high and low, or 1.86%. For the last week, the stock has had daily average volatility of 3.27%.

Since the AtriCure has been rising for 6 days in a row, the risk over the next couple of days has increased. We don't expect a major reaction as the stock is in very good shape technically, and therefore hold a positive evaluation despite the very short term risk.

Our recommended stop-loss: $40.37 (-3.06%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 6 days ago.)

Trading Expectations (ATRC) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect AtriCure to open at $41.77, and during the day (based on 14 day Average True Range), to move between $40.83 and $42.45, which gives a possible trading interval of +/-$1.61 (+/-3.95%) up or down from last closing price. If AtriCure takes out the full calculated possible swing range there will be an estimated 3.95% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $40.89, some $0.750 (1.80%) from the current price of $41.64, our system finds the risk reward attractive.

Is AtriCure stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for AtriCure stock to perform well in the short-term.

Current score: 3.662 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $41.77 ( 0.312%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk